Perspectives in Genetics and Sickle Cell Disease Prevention in Africa: Beyond the Preliminary Data from Cameroon

Public Health Genomics

Volumn 18, Issue 4, 2015, Pages 237-241

  Wonkam, Ambroise ^a   Ngo Bitoungui, Valentina Josiane ^b   Ngogang, Jeanne ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Cameroon; Genetics; Prevention; Sickle cell disease; Sub Saharan Africa

Indexed keywords

HEMOGLOBIN F; HEMOGLOBIN A; HEMOGLOBIN AA; HEMOGLOBIN ALPHA CHAIN;

AFRICA; ALPHA THALASSEMIA; ARTICLE; CAMEROON; DISEASE ASSOCIATION; FOLLOW UP; GENETIC VARIABILITY; GLOBIN GENE; HEALTH CARE POLICY; HUMAN; INHERITANCE; MEDICAL ABORTION; MEDICAL GENETICS; PHENOTYPE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PUBLIC HEALTH; SECONDARY PREVENTION; SICKLE CELL ANEMIA; ANEMIA, SICKLE CELL; ATTITUDE TO HEALTH; DISEASE MANAGEMENT; ETHICS; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; GENOMICS; HUMAN GENOME; LEGISLATION AND JURISPRUDENCE; PREGNANCY; PROCEDURES; PSYCHOLOGY; SOCIOECONOMICS; THALASSEMIA; THERAPEUTIC ABORTION;

ABORTION, THERAPEUTIC; ALPHA-GLOBINS; ANEMIA, SICKLE CELL; CAMEROON; DISEASE MANAGEMENT; FEMALE; FETAL HEMOGLOBIN; GENE DELETION; GENE FREQUENCY; GENETIC COUNSELING; GENETIC TESTING; GENETIC VARIATION; GENETICS, MEDICAL; GENOME, HUMAN; GENOMICS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HEMOGLOBIN A; HUMANS; PHENOTYPE; PREGNANCY; PRENATAL DIAGNOSIS; SECONDARY PREVENTION; SOCIOECONOMIC FACTORS; THALASSEMIA;

EID: 84937971799     PISSN: 16624246     EISSN: 16628063     Source Type: Journal    
DOI: 10.1159/000431020     Document Type: Article

References (35)

1. Weatherall DJ, Clegg JB: Inherited haemoglobin disorders: An increasing global health problem. Bull World Health Organ 2001; 79: 704-712.
2. Njamnshi AK, Wonkam A, Djientcheu Vde P, et al: Stroke may appear to be rare in Saudi-Arabian and Nigerian children with sickle cell disease, but not in Cameroonian sickle cell patients. Br J Haematol 2006; 133: 210.
3. Wonkam A, Njamnshi AK, Angwafo FF 3rd: Knowledge and attitudes concerning medical genetics amongst physicians and medical students in Cameroon (sub-Saharan Africa). Genet Med 2006; 8: 331-338.
4. Sheth S, Licursi M, Bhatia M: Sickle cell disease: Time for a closer look at treatment options? Br J Haematol 2013; 162: 455-464.
5. Locatelli F, Kabbara N, Ruggeri A, et al: Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 2013; 122: 1072-1078.
6. Wonkam A, Mba CZ, Mbanya D, Ngogang J, Ramesar R, Angwafo FF 3rd: Psychosocial burden of sickle cell disease on parents with an affected child in Cameroon. J Genet Couns 2014; 23: 192-201.
7. Wonkam A, Njamnshi AK, Mbanya D, Ngogang J, Zameyo C, Angwafo FF 3rd: Acceptability of prenatal diagnosis by a sample of parents of sickle cell anemia patients in Cameroon (sub-Saharan Africa). J Genet Couns 2011; 20: 476-485.
8. Adeyemi AS, Adekanle DA: Knowledge and attitude of female health workers towards prenatal diagnosis of sickle cell disease. Niger J Med 2007; 16: 268-270.
9. Adeola Animasahun B, Nwodo U, Njokanma OF: Prenatal screening for sickle cell anemia: Awareness among health professionals and medical students at the Lagos University Teaching Hospital and the concept of prevention by termination. J Pediatr Hematol Oncol 2012; 34: 252-256.
10. Durosinmi MA, Odebiyi AI, Adediran IA, Akinola NO, Adegorioye DE, Okunade MA: Acceptability of prenatal diagnosis of sickle cell anaemia (SCA) by female patients and parents of SCA patients in Nigeria. Soc Sci Med 1995; 41: 433-436.
11. Brown BJ, Okereke JO, Lagunju IA, Orimadegun AE, Ohaeri JU, Akinyinka OO: Burden of health-care of carers of children with sickle cell disease in Nigeria. Health Soc Care Community 2010; 18: 289-295.
12. Wonkam A, de Vries J, Royal CD, Ramesar R, Angwafo FF 3rd: Would you terminate a pregnancy affected by sickle cell disease? Analysis of views of patients in Cameroon. J Med Ethics 2014; 40: 615-620.
13. Wonkam A, Mba CZ, Mbanya D, Ngogang J, Ramesar R, Angwafo FF 3rd: Psychosocial stressors of sickle cell disease on adult patients in Cameroon. J Genet Couns 2014; 23: 948-956.
14. Wonkam A, Muna W, Ramesar R, Rotimi CN, Newport MJ: Capacity-building in human genetics for developing countries: initiatives and perspectives in sub-Saharan Africa. Public Health Genomics 2010; 13: 492-494.
15. Wonkam A, Tekendo CN, Sama DJ, Zambo H, Dahoun S, Bena F, Morris MA: Initiation of a medical genetics service in sub-Saharan Africa: experience of prenatal diagnosis in Cameroon. Eur J Med Genet 2011; 54:e399-e404.
16. Wonkam A, Ngongang Tekendo C, Zambo H, Morris MA: Initiation of prenatal genetic diagnosis of sickle cell anaemia in Cameroon (sub-Saharan Africa). Prenat Diagn 2011; 31: 1210-1212.
17. Akinyanju OO, Disu RF, Akinde JA, Adewole TA, Otaigbe AI, Emuveyan EE: Initiation of prenatal diagnosis of sickle-cell disorders in Africa. Prenat Diagn 1999; 19: 299-304.
18. Wonkam A, Ponde C, Nicholson N, Fieggen K, Ramessar R, Davidson A: The burden of sickle cell disease in Cape Town. S Afr Med J 2012; 102: 752-754.
19. Wonkam A, Hurst S: A call for policy action in sub-Saharan Africa to rethink diagnostics for pregnancy affected by sickle cell disease: differential views of medical doctors, parents and adult patients predict value conflicts in Cameroon. OMICS 2014; 18: 472-480.
20. Xu J, Peng C, Sankaran VG, et al: Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 2011; 334: 993-996.
21. Wonkam A, Ngo Bitoungui VJ, Vorster AA, et al: Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon. PLoS One 2014; 9:e92506.
22. Lettre G, Sankaran VG, Bezerra MA, et al: DNA polymorphisms at the BCL11A, HBS1LMYB, and beta-globin loci associated with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 2008; 105: 11869-11874.
23. Makani J, Menzel S, Nkya S, et al: Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood 2011; 117: 1390-1392.
24. Mtatiro SN, Makani J, Mmbando B, Thein SL, Menzel S, Cox SE: Genetic variants at HbFmodifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania. Am J Hematol 2015; 90:E1-E4.
25. Wonkam A, Rumaney MB, Ngo Bitoungui VJ, Vorster AA, Ramesar R, Ngogang J: Coinheritance of sickle cell anemia and -thalassemia delays disease onset and could improve survival in Cameroonian patients (sub-Saharan Africa). Am J Hematol 2014; 89: 664-665.
26. Rumaney MB, Ngo Bitoungui VJ, Vorster AA, et al: The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS One 2014; 9:e100516.
27. Hsu LL, Miller ST, Wright E, et al: Alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol 2003; 25: 622-628.
28. Cox SE, Makani J, Soka D, et al: Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania. Br J Haematol 2014; 165: 699-706.
29. Flanagan JM, Frohlich DM, Howard TA, et al: Genetic predictors for stroke in children with sickle cell anemia. Blood 2011; 117: 6681-6684.
30. Ashley-Koch AE, Okocha EC, Garrett ME, et al: MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol 2011; 155: 386-394.
31. Desai AA, Zhou T, Ahmad H, et al: A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease. Am J Respir Crit Care Med 2012; 186: 359-368.
32. Bean CJ, Boulet SL, Ellingsen D, et al: Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood 2012; 120: 3822-3828.
33. Wonkam A, Mayosi BM: Genomic medicine in Africa: promise, problems and prospects. Genome Med 2014; 6: 11.
34. Alwan A, Modell B: Recommendations for introducing genetics services in developing countries. Nat Rev Genet 2003; 4: 61-68.
35. H3Africa Consortium: Research capacity. Enabling the genomic revolution in Africa. Science 2014; 344: 1346-1348.